Publications

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. 

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, et al.  Nat Commun. 2016 Sep 7;7:12675. doi: 10.1038/ncomms...


Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching PA, Beckmann MW, Gago-Dominguez M, et al. Int J Cancer. 2017 Nov 1;141(9):1830-1840. ...


Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, et al.  Genet Med. 2016 Oct 6. doi: 10.1038/gim.2016.14...


Genetic predisposition to ductal carcinoma in situ of the breast.

Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, et al.  Breast Cancer Res. 2016; 18: 22. Published on...


Genetic predisposition to ductal carcinoma in situ of the breast. 

Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, Papouli E, et al.  Breast Cancer Res. 2016 Feb 17;18(1):22....


Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, et al.  Hum Genet. 20...


Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. 

Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, Dunning AM, et al.  Hum Genet. 2015 Nov 30. [Epub ahead of print]...


Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Decadence.

Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, et al.  PLoS Med. 2016 Aug 23;13(8):e1002105. doi: 10....


Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, et al. Nat Genet. 2017 Jun;49(6):834-841. doi: 10.1038/ng.3841. E...


Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Ben Zhang, Xiao-Ou Shu, Ryan J. Delahanty, Chenjie Zeng, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, et al. J Natl Cancer Inst (2015) 107(11): dj...


Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. 

Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, et al. Nat Commun. 2016 Apr 27;7:11375. d...


Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. 

Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, et al.  Breast Cancer Res. 2016 Jun 21;18(1):64. doi: 10.1186/s...


Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, et al. Nat Genet. 2017 Dec;49(12):1767-1778. doi: 10.103...


In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women-A GWAS Study Using the iCOGS Custom Genotyping Array.

Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman KH, Sprangers MA, Hall P.  PLoS One. 2015 Oct 15;10(10):e0140563. doi: 10.1371/jo...


Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. 

Brand JS, Colzani E, Johansson AL, Giesecke J, Clements M, Bergh J, Hall P, Czene K.  J Infect. 2016 Apr 8. pii: S0163-4453(16)30030-5. doi: 10.1016/...


Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. 

Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, et al.  Nat Genet. 2015 Sep 28. doi: 10.1038/ng.3412. [Epub...


Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer. 

Strand F, Humphreys K, Eriksson M, Li J, Andersson TM, Törnberg S, Azavedo E, Shepherd J, et al.  Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30427...


Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.

Andersson TM, Crowther MJ, Czene K, Hall P, Humphreys K. Am J Epidemiol. 2017 Nov 1;186(9):1065-1073. doi: 10.1093/aje/kwx178....


No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, et al.  J Med Genet. 2016 Feb 26. pii: jmedgenet-2015-103529. ...


Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. 

Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.  Breast Cancer Res. 2016 Oct 5;18(1):100. PMID: 27716311...